Skip to Content
HubMed
  • Solutions
    • Overview
    • Medea™
    • Adam™
  • Industries
    • Overview
    • Nutraceuticals
    • Cosmetics
    • Medical Devices
    • Contract Research Organization
  • Why Hubmed™
    • Overview
    • Swiss made quality
    • Data security
    • AI-Assisted
    • PICO Framework
    • End-to-End Integration
  • Resources
    • Blog
    • Press Room
    • Medea™ | Early Adopter Program
    • Medea™ | Referral Program
    • Medea™ | CER Maintenance Calculator
    • Medea™ | ROI & Savings
  • About Us
  • Contact Us 
HubMed
      • Solutions
        • Overview
        • Medea™
        • Adam™
      • Industries
        • Overview
        • Nutraceuticals
        • Cosmetics
        • Medical Devices
        • Contract Research Organization
      • Why Hubmed™
        • Overview
        • Swiss made quality
        • Data security
        • AI-Assisted
        • PICO Framework
        • End-to-End Integration
      • Resources
        • Blog
        • Press Room
        • Medea™ | Early Adopter Program
        • Medea™ | Referral Program
        • Medea™ | CER Maintenance Calculator
        • Medea™ | ROI & Savings
      • About Us
    • Contact Us 

    Expert Perspectives on Biotech R&D Trends

    • Blogs:
    • All
    • AI in Life Sciences
    • Regulatory Updates
    • Scientific Methodology
    • Industry Deep-Dives
    • Success Stories
    • Company News
    Blogs
    • All
    • AI in Life Sciences
    • Regulatory Updates
    • Scientific Methodology
    • Industry Deep-Dives
    • Success Stories
    • Company News
    Top 5 Reasons Notified Bodies Challenge CERs Under EU MDR (And How to Avoid Them)
    When a Medical Device Manufacturer receives a list of non-conformities or a request for additional information from a Notified Body, the cause is rarely structural or formatting-related. Under the Eur...
    CER Clinical Evaluation Report Compliance Risk Management EU MDR EUDAMED MDR (Medical Device Regulation) MDR Compliance SOTA (State of the Art)
    7 Oct 2026
    0 62
    Regulatory Updates
    Demystifying AI in Regulatory Compliance: Why Medea™ Uses "Assisted AI" (Not "AI-Driven")
    Introduction The medical device and life sciences industries are navigating an era of unprecedented regulatory complexity. With the demands of the EU MDR and ongoing post-market surveillance requireme...
    AI Innovation Clinical Evaluation Report EU MDR MDR (Medical Device Regulation) Medea Regulatory Affairs
    20 Sept 2026
    0 169
    AI in Life Sciences
    HubMed Acting CEO Amedeo Chiappini to Join Expert Panel on Regulatory Scaling and Supply Chain Resilience at CPHI Milan
    As regulatory scrutiny intensifies across global markets, health and nutraceutical brands face a critical challenge: how do you scale product lines rapidly without creating bottlenecks in quality, com...
    AI Innovation Events Medea Nutraceuticals R&D Acceleration Swiss-Made AI
    14 Sept 2026
    0 107
    Company News
    HubMed at CPHI Milan: Experience the Future of AI-Assisted Regulatory & Scientific Compliance Live
    We are thrilled to announce that HubMed will be at CPHI Milan (October 6–8) as an Official Sponsor ! As global regulatory demands intensify across MedTech, Nutraceuticals, and Life Sciences, keeping p...
    AI Innovation CRO Efficiency Events MDR Compliance Medea Nutraceuticals
    3 Aug 2026
    0 336
    Company News
    EU MDR 2017/745: The Compliance Deadline That Cannot Be Ignored — And What Happens If You Miss It
    Five years after its full application, EU MDR 2017/745 is no longer a transition challenge. It is the new standard. And Notified Bodies are running out of patience. When the EU Medical Device Regulati...
    CER Clinical Evaluation Report Compliance Risk Management EUDAMED MDR (Medical Device Regulation) MDR Compliance Medical Devices Time-to-Market
    4 Jul 2026
    0 217
    Regulatory Updates
    Navigating EU MDR Annex XIV: How to Eliminate Literature Review Bottlenecks in Clinical Evaluations
    Introduction The European Medical Device Regulation (EU MDR 2017/745) has fundamentally transformed the regulatory landscape for the MedTech sector. Moving away from the historical pre-market approval...
    Clinical Evaluation Report EU MDR MDR Compliance Medea Technical Files
    1 Jun 2026
    0 359
    Regulatory Updates
    What is EUDAMED and Why is it Critical for Medical Device Manufacturers?
    Introduction Digital transformation has fundamentally disrupted the life sciences sector, and regulatory frameworks are evolving rapidly to keep pace. At the center of this compliance revolution sits ...
    Clinical Evaluation Report EU MDR EUDAMED MDR (Medical Device Regulation) MDR Compliance Medea Technical Files
    25 May 2026
    0 266
    Regulatory Updates
    How AI Is Transforming CRO Efficiency in Clinical Research
    Introduction Contract Research Organizations (CROs) operate in one of the most demanding environments in life sciences. Increasing trial complexity, evolving global regulations, and rising operational...
    AI Innovation Automation CRO Efficiency Clinical Research Medea Operational Profitability Time-to-Market
    1 May 2026
    0 261
    Industry Deep-Dives
    Using the PICO Framework in Comparative Effectiveness Research (CER): A Practical Guide for Medical Device Manufacturers and CROs
    Introduction The PICO framework is one of the most effective methodologies for structuring Comparative Effectiveness Research (CER) in the medical device sector. By clearly defining Population , Inter...
    CER Clinical Evaluation Report Literature Review MDR Compliance Medical Devices PICO Framework
    1 May 2026
    0 250
    Scientific Methodology
    How AI-Assisted Solutions Accelerate Product Development in Nutraceuticals, Cosmetics, and Medical Devices
    Introduction Artificial intelligence is reshaping the way nutraceutical, cosmetic, and medical device companies innovate. These industries face increasing pressure to deliver safer, more effective, an...
    AI Innovation Cosmetics Literature Review MDR Compliance Medical Devices Nutraceuticals R&D Acceleration
    2 Feb 2026
    0 314
    AI in Life Sciences
    The Journey of Early Drug Discovery
    Introduction Early drug discovery is a complex, multidisciplinary journey that lays the foundation for future therapeutic breakthroughs. The process begins long before clinical trials — with the ident...
    Bioactive Compounds Early Drug Discovery In-Silico Screening Medea Preclinical Research R&D Acceleration
    30 Dec 2025
    0 322
    AI in Life Sciences
    USEFUL LINKS
    • Home
    • Solutions
    • Industries
    • Why Hubmed™
    • About us
      Privacy Policy
    • Contact us
    ABOUT US

    HubMed™ is a Swiss-made, AI-assisted platform for Life Sciences R&D and regulatory compliance, connecting preclinical discovery (Adam™) with clinical evaluation under EU MDR (Medea™). 

    It accelerates research-intensive work — literature search, screening, appraisal and structured drafting — while qualified experts stay in control of every scientific and regulatory decision.

    CONNECT WITH US
    • Contact us
    • info@hubmed.ch

    Follow us
    2026 Copyright © HubMed™ Technologies GmbH  |  Accelerating Discovery, Ensuring Compliance
    Powered by Odoo - Create a free website